Advertisement

Topics

New Combination Treatment, Vyxeos, Approved for Acute Myeloid Leukemia

07:08 EDT 3 Aug 2017 | Drugs.com

THURSDAY, Aug. 3, 2017 -- The combination chemotherapy drug Vyxeos (daunorubicin and cytarabine) has been approved by the U.S. Food and Drug Administration as the first treatment for certain high-risk types of acute myeloid leukemia (AML). AML is...

Original Article: New Combination Treatment, Vyxeos, Approved for Acute Myeloid Leukemia

NEXT ARTICLE

More From BioPortfolio on "New Combination Treatment, Vyxeos, Approved for Acute Myeloid Leukemia"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...